Back to regulatory watch
Federal RegisterGuidance and regulationPublished October 9, 2026

Medical Devices; Immunology and Microbiology Devices; Classification of the Hematopoietic Cell Enrichment Kit

Updated under an hour ago ()

The Food and Drug Administration (FDA) is classifying the hematopoietic cell enrichment kit into class II (special controls). The special controls that apply to the device type are identified in this order and will be part of the codified language for classification of the hematopoietic cell enrichment kit. We are taking this action because we have determined that classifying the device into class II will provide a reasonable assurance of the safety and effectiveness of the device. We believe this action will also enhance patients' access to beneficial innovative devices, in part by reducing regulatory burdens.

Tags
health IT, Rule, Health and Human Services Department, Food and Drug Administration
Related exam domains
CISM 3: Information Security Program; CISA 1: Information System Auditing Process
Source record id
2026-20725
First seen by InfoSec Signals
10/9/2026

Source: Federal Register API, Office of the Federal Register, National Archives and Records Administration about this source more from it

Exam domain labels come from a keyword heuristic and are study hints, not an official mapping. The summary is the publisher's own text, shortened; the linked record is authoritative.

Your cookie choices
We use essential cookies to run this site, and, only with your consent, an advertising cookie from Google to measure whether our ads lead to sign-ups and subscriptions. See our for details.